Skip to content
Screener

Mirum Pharmaceuticals, Inc. MIRM Other Non-Current Assets

Other Non-Current Assets at other companies

Gilead Sciences logo
Gilead SciencesGILD
$295M-20.1%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$2.52M-64.8%
LQD
Liquidia CorporationLQDA
$16.9M+8.7%
ALN
Alnylam PharmaceuticalsALNY
$65.13M+13.9%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$18.62M+12.1%
Arrowhead Research logo
Arrowhead ResearchARWR
$4.89M+272%

Other financials

Income statement

See full
Revenue$176.2M+37.9%
Operating income-$42.5M-753%
Net income-$67.2M-1,047%
EPS (diluted)-$1.06-783%

Balance sheet

See full
Cash & equivalents$262.7M+39.4%
Total debt$12.9M+29.2%
Total equity-$10.4M-104%
Total assets$1.0B+44.0%

Cash flow

See full
Operating cash flow-$44.3M-468%
CapEx$23.0K-81.7%
Free cash flow-$44.3M-472%

Valuation

See full
Market cap$6.45B+144%
Enterprise value$6.2B+151%
P/S10.4×+4.3×

Profitability

See full
Operating margin-134.9%-151pp
Net margin-139.2%-156pp
FCF margin-37%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.9×-0.3×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001759425-26-000045
Line itemJune 30,2026December 31,2025
Property and equipment, net2,2511,862
Operating lease right-of-use assets12,0248,741
Intangible assets, net247,388260,921
Other assets22,24412,018
Total assets$1,044,981$842,813
Liabilities and Stockholders’ (Deficit) Equity
Current liabilities:
Accounts payable$23,427$9,614

Item 1. Financial Statements (Unaudited)

FAQ

What is Mirum Pharmaceuticals, Inc.'s other non-current assets?
Mirum Pharmaceuticals, Inc. (MIRM) reported other non-current assets of $22.24M in Q2 2026.
How has Mirum Pharmaceuticals, Inc.'s other non-current assets changed year-over-year?
Mirum Pharmaceuticals, Inc.'s other non-current assets increased by 225.1% year-over-year, from $6.84M to $22.24M.
What is the long-term trend for Mirum Pharmaceuticals, Inc.'s other non-current assets?
Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s other non-current assets has grown at a 56.7% compound annual growth rate (CAGR), from $1.27M to $12.02M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Mirum Pharmaceuticals, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude